Showing 1 - 10 of 160
By approximating a stochastic process by means of spline interpolation of its sample-paths, a time dependent state-space model is introduced. Then we derive the expression of the associated transition matrix that allows to obtain a discrete model useful in applications. In order to essay the...
Persistent link: https://www.econbiz.de/10011241299
At the ultra high frequency level, the notion of price of an asset is very ambiguous. Indeed, many different prices can be defined (last traded price, best bid price, mid price, etc.). Thus, in practice, market participants face the problem of choosing a price when implementing their strategies....
Persistent link: https://www.econbiz.de/10010666235
This paper constructs a class of multivariate Gaussian marked Poisson processes to model asset returns. The model proposed accommodates the cross section properties of trades, allows for returns to be correlated conditional on trading activity, and preserves the economic intuition of normality...
Persistent link: https://www.econbiz.de/10010941709
Persistent link: https://www.econbiz.de/10012013851
Persistent link: https://www.econbiz.de/10012194856
This project applies the methods of functional data analysis (FDA) to intra-daily returns of US corporations. It focuses on an extension of the Capital Asset Pricing Model (CAPM) to such returns. The CAPM is essentially a linear regression with the slope coefficient . Returns of an asset are...
Persistent link: https://www.econbiz.de/10009468694
My doctoral research dissertation focuses on two aspects of functional data analysis (FDA): FDA under spatial interdependence and FDA for multi-level data.The first part of my thesis focuses on developing modeling and inference procedure for functional data under spatial dependence. The...
Persistent link: https://www.econbiz.de/10009475878
Persistent link: https://www.econbiz.de/10005613180
Persistent link: https://www.econbiz.de/10012141632
This paper proposes a systemic risk index based on Functional Data Analysis (FDA), overcoming salient shortcomings of standard methodologies related to data usage, data sparseness, and high dimensionality issues. Using Mexican data, a set of systemic risk indexes are constructed and we show that...
Persistent link: https://www.econbiz.de/10011788936